Making the Case for Gene Therapy in a Tough Market

Time: 3:15 pm
day: Day One PM

Details:

• Alternative funding strategies for a tough financing market
• Unusual business models for ultra-rare indications and emerging economies
• Making the commercial proposition for gene therapies more valuable

Speakers:

Sheila Mikhail Sheila has started and successfully exited several gene therapy companies, including Chatham Therapeutics (sold to Baxter 2014), Bamboo Therapeutics (sold to Pfizer 2016), and AskBio Read more